{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:01:50Z","timestamp":1767927710822,"version":"3.49.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017165","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T17:01:20Z","timestamp":1298048480000},"page":"e17165","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["MEK2 Is Sufficient but Not Necessary for Proliferation and Anchorage-Independent Growth of SK-MEL-28 Melanoma Cells"],"prefix":"10.1371","volume":"6","author":[{"given":"Chih-Shia","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl J.","family":"Dykema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Cherba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig P.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle A.","family":"Furge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Duesbery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer.","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"key":"ref2","first-page":"1800","article-title":"Relative Reciprocity of NRAS and PTEN\/MMAC1 Alterations in Cutaneous Melanoma Cell Lines.","volume":"60","author":"H Tsao","year":"2000","journal-title":"Cancer Res"},{"key":"ref3","first-page":"3728","article-title":"Mitogen-actived Protein Kinase Activation Is an Early Event in Melanoma Progression.","volume":"8","author":"C Cohen","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1074\/jbc.M212929200","article-title":"Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling.","volume":"278","author":"B Govindarajan","year":"2003","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1038\/sj.onc.1208152","article-title":"Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.","volume":"23","author":"H Tanami","year":"2004","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/0008-5472.CAN-03-3433","article-title":"V599EB-RAF is an Oncogene in Melanocytes.","volume":"64","author":"C Wellbrock","year":"2004","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1091\/mbc.E04-12-1087","article-title":"Involvement of PI3K and MAPK Signaling in bcl-2-induced Vascular Endothelial Growth Factor Expression in Melanoma Cells.","volume":"16","author":"D Trisciuoglio","year":"2005","journal-title":"Mol Biol Cell"},{"key":"ref8","first-page":"5669","article-title":"Treatment of Metastatic Melanoma with an Orally Available Inhibitor of the Ras-Raf-MAPK Cascade.","volume":"63","author":"EA Collisson","year":"2003","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature04304","article-title":"BRAF mutation predicts sensitivity to MEK inhibition.","volume":"439","author":"DB Solit","year":"2006","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1073\/pnas.052707699","article-title":"Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase.","volume":"99","author":"H-M Koo","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1535-7163.MCT-05-0145","article-title":"BRAF status and mitogen-activated protein\/extracellular signal-regulated kinase kinase 1\/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin.","volume":"4","author":"RJ Abi-Habib","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.","volume":"26","author":"PJ Roberts","year":"2007","journal-title":"Oncogene"},{"key":"ref13","article-title":"Highly Selective MEK inhibitors.","author":"CS Lee","year":"2010","journal-title":"Current Enzyme Inhibition"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1200\/JCO.2005.14.415","article-title":"Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies.","volume":"23","author":"PM LoRusso","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjc.6603291","article-title":"Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.","volume":"95","author":"T Eisen","year":"2006","journal-title":"Br J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.devcel.2007.03.009","article-title":"Mek1\/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.","volume":"12","author":"FA Scholl","year":"2007","journal-title":"Dev Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0960-9822(99)80164-X","article-title":"Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta.","volume":"9","author":"S Giroux","year":"1999","journal-title":"Current Biology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1128\/MCB.23.14.4778-4787.2003","article-title":"Mek2 Is Dispensable for Mouse Growth and Development.","volume":"23","author":"L-F Belanger","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-8-337","article-title":"Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.","volume":"8","author":"L Voisin","year":"2008","journal-title":"BMC Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1158\/0008-5472.CAN-08-1963","article-title":"Selective Role for Mek1 but not Mek2 in the Induction of Epidermal Neoplasia.","volume":"69","author":"FA Scholl","year":"2009","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","article-title":"Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.","volume":"270","author":"Z Xia","year":"1995","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"38953","DOI":"10.1074\/jbc.C000684200","article-title":"MEK inhibition enhances paclitaxel-induced tumor apoptosis.","volume":"275","author":"JP MacKeigan","year":"2000","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1755-148X.2008.00520.x","article-title":"Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation.","volume":"22","author":"Y Estrada","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor.","volume":"280","author":"NS Duesbery","year":"1998","journal-title":"Science"},{"key":"ref25","first-page":"285","article-title":"Pathogenesis of Bacillus anthracis: the role of Anthrax toxins.","author":"Y Singh","year":"2005"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(99)01502-1","article-title":"Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS\/IFNgamma-induced release of NO and TNFalpha.","volume":"462","author":"R Pellizzari","year":"1999","journal-title":"FEBS Lett"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/bj3520739","article-title":"Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.","volume":"352","author":"G Vitale","year":"2000","journal-title":"Biochem J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1006\/bbrc.1998.9040","article-title":"Anthrax Lethal Factor Cleaves the N-Terminus of MAPKKs and Induces Tyrosine\/Threonine Phosphorylation of MAPKs in Cultured Macrophages.","volume":"248","author":"G Vitale","year":"1998","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.061031898","article-title":"Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.","volume":"98","author":"NS Duesbery","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/35000065","article-title":"A conserved docking motif in MAP kinases common to substrates, activators and regulators.","volume":"2","author":"T Tanoue","year":"2000","journal-title":"Nat Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1074\/jbc.M211262200","article-title":"Anthrax Lethal Factor Proteolysis and Inactivation of MAPK Kinase.","volume":"278","author":"AP Chopra","year":"2003","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/bj20031382","article-title":"Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.","volume":"378","author":"AJ Bardwell","year":"2004","journal-title":"Biochem J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/1535-7163.MCT-06-0433","article-title":"Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.","volume":"5","author":"ON Ikediobi","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.1073163","article-title":"Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition.","volume":"297","author":"JM Park","year":"2002","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1158\/0008-5472.CAN-06-4571","article-title":"Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.","volume":"67","author":"KA Furge","year":"2007","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/sj.onc.1210256","article-title":"Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling.","volume":"26","author":"KA Furge","year":"2007","journal-title":"Oncogene"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases.","volume":"103","author":"RJ Davis","year":"2000","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","article-title":"ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.","volume":"68","author":"PP Roux","year":"2004","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1021\/cr000241p","article-title":"MAP kinases.","volume":"101","author":"Z Chen","year":"2001","journal-title":"Chem Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.","volume":"298","author":"GL Johnson","year":"2002","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades.","volume":"410","author":"L Chang","year":"2001","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/onc.2008.459","article-title":"Mek1\/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin.","volume":"28","author":"FA Scholl","year":"2009","journal-title":"Oncogene"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin.","volume":"414","author":"KA Bradley","year":"2001","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.","volume":"100","author":"HM Scobie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tibs.2007.08.010","article-title":"The mammalian N-end rule pathway: new insights into its components and physiological roles.","volume":"32","author":"T Tasaki","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/1535-7163.MCT-07-2229","article-title":"Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.","volume":"7","author":"Y Ding","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/oxfordjournals.jbchem.a124524","article-title":"Mitogen-activated protein (MAP) kinase phosphorylation of MAP kinase kinase: determination of phosphorylation sites by mass spectrometry and site-directed mutagenesis.","volume":"116","author":"SJ Mansour","year":"1994","journal-title":"J Biochem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0076-6879(07)38025-7","article-title":"Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathways.","volume":"438","author":"JL Bromberg-White","year":"2008","journal-title":"Methods Enzymol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics.","volume":"5","author":"RC Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nbt1242","article-title":"Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project.","volume":"24","author":"TA Patterson","year":"2006","journal-title":"Nat Biotechnol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies.","volume":"439","author":"AH Bild","year":"2006","journal-title":"Nature"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.","volume":"25","author":"M Ashburner","year":"2000","journal-title":"Nat Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T13:12:21Z","timestamp":1559999541000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017165"}},"subtitle":[],"editor":[{"given":"Benjamin","family":"Rich","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017165","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,18]]}}}